CPhI China set for June 2013

AMSTERDAM and SHANGHAI -- CPhI announces that CPhI China, an event organised by UBM Live and UBM Sinoexpo is returning to the Shanghai New International Expo Center (25-27 June 2013, Shanghai) for the 13th consecutive year -- with an increased scale, more informative exhibition and regional networking opportunities and a greater range of content services than it has ever offered before.

With a view to enhancing the customer experience and ROI value, CPhI China has added mobile applications, high value conferences, a live laboratory showcase and re-launched the show daily. Furthermore, the 2013 event has a strong focus on R&D with LABWorld, BioPharma and ICSE all contained in one hall. China has increasingly become a focal point of the pharmaceutical industry and is now the 3 rd largest market in the world. Fuelled by increasing healthcare demands within its own borders as well as by international companies seeking manufacturing facilities, China's hunger for foreign partnerships and pharmaceutical ingredients presents a great opportunity for international and domestic suppliers and buyers.

CPhI China is back this year as the main event for the pharmaceutical ingredients industry in the fast growing Chinese market. With some 2,300 exhibitors and 30,000 visitors from more than 100 countries, the event is a unique one-stop platform to meet current partners, build new relationships, evaluate pharmaceutical products and learn about the latest industry trends.

Co-located events re-confirmed for the 2013 edition will be P-MEC China, which covers machinery and equipment; ICSE China, for companies providing outsourcing services in custom synthesis and clinical trials; BioPh China, a dedicated platform for biopharmaceuticals; and InnoPack, focussed on bringing global packaging solutions to the Chinese pharma companies. Additionally, following huge demand in 2012, this year will also see a significant expansion of co-located event, LABWorld China – which will focus on innovation and new developments, providing a forum for increased education and networking for businesses in the laboratory, analytical and biotech equipment sector.

The number of exhibitors already registered has seen a tremendous upsurge thanks to increased Chinese manufacturing opportunities and huge growth in China's generics sector. This rapid development, coupled with the evolving regulatory landscape is attracting both domestic and international investors to the Chinese market.